ABUS icon

Arbutus Biopharma
ABUS

Overview Fund Activity

49 hedge funds and large institutions have $73.1M invested in Arbutus Biopharma in 2016 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
-2
Holders Change %
-3.92%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
14
Reduced
15
Closed
10
Calls
$517K
Puts
$368K
Net Calls
+$149K
Net Calls Change
-$74K

Top Buyers

1
Primecap Management
1
Primecap Management
California
$15.9M
2
B
2
Bailard
California
$888K
3
DCM
3
Dialectic Capital Management
Connecticut
$825K
4
SM
4
Sabby Management
Florida
$4.95M
5
DCM
5
DAFNA Capital Management
California
$476K

Top Sellers

1
Franklin Resources
1
Franklin Resources
California
$0
2
Millennium Management
2
Millennium Management
New York
$3.3M
3
Citadel Advisors
3
Citadel Advisors
Florida
$0
4
D.E. Shaw & Co
4
D.E. Shaw & Co
New York
$7.07M
5
TI
5
Telemetry Investments
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CS
51
Candriam SCA
Luxembourg
– -$445K -100,000 Closed
LCM
52
Landscape Capital Management
New Jersey
– -$246K -55,273 Closed
TI
53
Trexquant Investment
Connecticut
– -$107K -24,028 Closed
AL
54
Airain Ltd
Guernsey
– -$92K -20,582 Closed
RFS
55
Rockefeller Financial Services
New York
– -$62K -13,932 Closed
WAM
56
Wealthspire Advisors (Maryland)
Maryland
– -$3K -600 Closed
1 2
3